Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Wellington, A. Boxall, P. Cross, E. Feil, W. Gaze, P. Hawkey, Ashley Johnson-Rollings, Davey Jones, N. Lee, W. Otten, Christopher Thomas, A. Williams (2013)
The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria.The Lancet. Infectious diseases, 13 2
I. Loo, X. Huijsdens, E. Tiemersma, A. Neeling, N. Sande-Bruinsma, D. Beaujean, A. Voss, J. Kluytmans (2007)
Emergence of Methicillin-Resistant Staphylococcus aureus of Animal Origin in HumansEmerging Infectious Diseases, 13
P. Patel, A. Kallen, M. Arduino (2010)
Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients.American journal of kidney diseases : the official journal of the National Kidney Foundation, 56 3
M. Fay, E. Feuer (1997)
Confidence intervals for directly standardized rates: a method based on the gamma distribution.Statistics in medicine, 16 7
M. David, S. Medvedev, S. Hohmann, B. Ewigman, R. Daum (2012)
Increasing Burden of Methicillin-Resistant Staphylococcus aureus Hospitalizations at US Academic Medical Centers, 2003–2008Infection Control & Hospital Epidemiology, 33
D. Burton, J. Edwards, T. Horan, J. Jernigan, S. Fridkin (2009)
Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.JAMA, 301 7
(2011)
of Health & Human Services
A. Kallen, Yi Mu, S. Bulens, A. Reingold, S. Petit, K. Gershman, S. Ray, L. Harrison, R. Lynfield, G. Dumyati, J. Townes, W. Schaffner, P. Patel, S. Fridkin (2010)
Health care-associated invasive MRSA infections, 2005-2008.JAMA, 304 6
M. David, R. Daum (2010)
Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging EpidemicClinical Microbiology Reviews, 23
Bala Hota, R. Weinstein (2006)
Community-associated Methicillin-resistant Staphylococcus aureusEmerging Infectious Diseases, 12
J. Hadler, S. Petit, M. Mandour, M. Cartter (2012)
Trends in Invasive Infection with Methicillin-Resistant Staphylococcus aureus, Connecticut, USA, 2001–2010Emerging Infectious Diseases, 18
Catherine Liu, A. Bayer, S. Cosgrove, R. Daum, S. Fridkin, R. Gorwitz, S. Kaplan, A. Karchmer, D. Levine, B. Murray, Michael Rybak, D. Talan, H. Chambers (2011)
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 3
R. Klevens, M. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L. Harrison, R. Lynfield, G. Dumyati, J. Townes, A. Craig, E. Zell, G. Fosheim, L. McDougal, R. Carey, S. Fridkin (2007)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States.JAMA, 298 15
Susan Huang, R. Platt (2003)
Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 36 3
Jane Single... (2013)
Management of Multidrug- resistant organisms in Healthcare settings
D. Talan, A. Krishnadasan, R. Gorwitz, G. Fosheim, B. Limbago, V. Albrecht, G. Moran (2011)
Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 53 2
J. Kluytmans, I. Overdevest, I. Willemsen, M. Bergh, K. Zwaluw, M. Heck, M. Rijnsburger, C. Vandenbroucke-Grauls, P. Savelkoul, B. Johnston, D. Gordon, James Johnson (2013)
Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 56 4
(2013)
Annual Estimates of the Resident Population for the United States, Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2011
M. Charlson, P. Pompei, Kathy Ales, C. MacKenzie (1987)
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.Journal of chronic diseases, 40 5
E. Klein, David Smith, R. Laxminarayan (2007)
Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005Emerging Infectious Diseases, 13
J. Casey, F. Curriero, S. Cosgrove, K. Nachman, B. Schwartz (2013)
High-density livestock operations, crop field application of manure, and risk of community-associated methicillin-resistant Staphylococcus aureus infection in Pennsylvania.JAMA internal medicine, 173 21
N. O’grady, M. Alexander, L. Burns, E. Dellinger, J. Garland, S. Heard, P. Lipsett, H. Masur, L. Mermel, M. Pearson, I. Raad, A. Randolph, M. Rupp, S. Saint (2002)
Guidelines for the prevention of intravascular catheter-related infections.American journal of infection control, 39 4 Suppl 1
A. Hidrón, J. Edwards, J. Patel, T. Horan, D. Sievert, D. Pollock, S. Fridkin (2008)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007Infection Control & Hospital Epidemiology, 29
P. Malani (2014)
National burden of invasive methicillin-resistant Staphylococcus aureus infection.JAMA, 311 14
M. Landrum, C. Neumann, C. Cook, Uzo Chukwuma, Michael Ellis, D. Hospenthal, C. Murray (2012)
Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010.JAMA, 308 1
J. Siegel, E. Rhinehart, M. Jackson, L. Chiarello (2007)
Management of multidrug-resistant organisms in health care settings, 2006.American journal of infection control, 35 10 Suppl 2
ImportanceEstimating the US burden of methicillin-resistant Staphylococcus aureus (MRSA) infections is important for planning and tracking success of prevention strategies. ObjectiveTo describe updated national estimates and characteristics of health care– and community-associated invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in 2011. Design, Setting, and ParticipantsActive laboratory-based case finding identified MRSA cultures in 9 US metropolitan areas from 2005 through 2011. Invasive infections (MRSA cultured from normally sterile body sites) were classified as health care–associated community-onset (HACO) infections (cultured ≤3 days after admission and/or prior year dialysis, hospitalization, surgery, long-term care residence, or central vascular catheter presence ≤2 days before culture); hospital-onset infections (cultured >3 days after admission); or community-associated infections if no other criteria were met. National estimates were adjusted using US census and US Renal Data System data. Main Outcomes and MeasuresNational estimates of invasive HACO, hospital-onset, and community-associated MRSA infections using US census and US Renal Data System data as the denominator. ResultsAn estimated 80 461 (95% CI, 69 515-93 914) invasive MRSA infections occurred nationally in 2011. Of these, 48 353 (95% CI, 40 195–58 642) were HACO infections; 14 156 (95% CI, 10 096-20 440) were hospital-onset infections; and 16 560 (95% CI, 12 806-21 811) were community-associated infections. Since 2005, adjusted national estimated incidence rates decreased among HACO infections by 27.7% and hospital-onset infections decreased by 54.2%; community-associated infections decreased by only 5.0%. Among recently hospitalized community-onset (nondialysis) infections, 64% occurred 3 months or less after discharge, and 32% of these were admitted from long-term care facilities. Conclusions and RelevanceAn estimated 30 800 fewer invasive MRSA infections occurred in the United States in 2011 compared with 2005; in 2011 fewer infections occurred among patients during hospitalization than among persons in the community without recent health care exposures. Effective strategies for preventing infections outside acute care settings will have the greatest impact on further reducing invasive MRSA infections nationally.
JAMA Internal Medicine – American Medical Association
Published: Nov 25, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.